Holdings of State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 7.4B $ including 7.4B $ in equities, 99.8 %
- Positions
- 147 in 6 countries
- Top ten
- 13.7 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Geron Corp | 16,613,693 | 24.8M $ | 0.33 % |
| 102 | Day One Biopharmaceuticals Inc | 1,113,401 | 23.9M $ | 0.32 % |
| 103 | Precigen Inc | 6,004,794 | 23.2M $ | 0.31 % |
| 104 | Vir Biotechnology Inc | 2,527,795 | 22.6M $ | 0.30 % |
| 105 | KalVista Pharmaceuticals Inc | 1,077,952 | 21.7M $ | 0.29 % |
| 106 | CytomX Therapeutics Inc | 4,511,036 | 21.2M $ | 0.29 % |
| 107 | Annexon Inc | 3,823,368 | 21.2M $ | 0.28 % |
| 108 | Kura Oncology Inc | 2,523,230 | 20.5M $ | 0.28 % |
| 109 | Inhibrx Biosciences Inc | 296,581 | 19.9M $ | 0.27 % |
| 110 | SELLAS Life Sciences Group Inc | 4,689,810 | 19.8M $ | 0.27 % |
| 111 | Janux Therapeutics Inc | 1,424,540 | 19.8M $ | 0.27 % |
| 112 | Compass Therapeutics Inc | 3,684,989 | 19.5M $ | 0.26 % |
| 113 | Savara Inc | 3,554,970 | 19.4M $ | 0.26 % |
| 114 | Rigel Pharmaceuticals Inc | 708,776 | 19.2M $ | 0.26 % |
| 115 | Sana Biotechnology Inc | 6,650,475 | 19.2M $ | 0.26 % |
| 116 | Cullinan Therapeutics Inc | 1,307,461 | 18.6M $ | 0.25 % |
| 117 | ARS Pharmaceuticals Inc | 2,213,506 | 17.8M $ | 0.24 % |
| 118 | ZENAS BIOPHARMA INC | 906,255 | 17.7M $ | 0.24 % |
| 119 | Xencor Inc | 1,422,163 | 17.2M $ | 0.23 % |
| 120 | Replimune Group Inc | 2,198,386 | 16.8M $ | 0.23 % |
| 121 | Sionna Therapeutics Inc | 416,630 | 16.7M $ | 0.22 % |
| 122 | Vor BioPharma Inc | 932,400 | 16.6M $ | 0.22 % |
| 123 | ArriVent Biopharma Inc | 701,088 | 16.2M $ | 0.22 % |
| 124 | Ironwood Pharmaceuticals Inc | 3,999,224 | 14M $ | 0.19 % |
| 125 | Bicara Therapeutics Inc | 701,643 | 14M $ | 0.19 % |
| 126 | Prime Medicine Inc | 3,979,993 | 13.9M $ | 0.19 % |
| 127 | Altimmune Inc | 4,353,091 | 13.4M $ | 0.18 % |
| 128 | Absci Corp | 4,448,453 | 13.3M $ | 0.18 % |
| 129 | Emergent BioSolutions Inc | 1,572,925 | 13.1M $ | 0.18 % |
| 130 | Allogene Therapeutics Inc | 5,212,606 | 12.7M $ | 0.17 % |
| 131 | HYPERLIQUID STRATEGIES INC | 2,451,336 | 12.5M $ | 0.17 % |
| 132 | 4D Molecular Therapeutics Inc | 1,318,068 | 12.3M $ | 0.17 % |
| 133 | Vanda Pharmaceuticals Inc | 1,704,031 | 11.8M $ | 0.16 % |
| 134 | REGENXBIO Inc | 1,363,810 | 11.4M $ | 0.15 % |
| 135 | Lexeo Therapeutics Inc | 1,862,707 | 10.7M $ | 0.14 % |
| 136 | Verastem Inc | 2,014,499 | 10.7M $ | 0.14 % |
| 137 | Arbutus Biopharma Corp | 2,268,065 | 10.2M $ | 0.14 % |
| 138 | Myriad Genetics Inc | 2,160,321 | 9.7M $ | 0.13 % |
| 139 | Prothena Corp PLC | 983,448 | 9.6M $ | 0.13 % |
| 140 | Ocugen Inc | 5,222,819 | 9.5M $ | 0.13 % |
| 141 | Rocket Pharmaceuticals Inc | 2,606,982 | 9.3M $ | 0.13 % |
| 142 | MiMedx Group Inc | 2,282,660 | 9M $ | 0.12 % |
| 143 | Akebia Therapeutics Inc | 6,038,997 | 8.4M $ | 0.11 % |
| 144 | Anavex Life Sciences Corp | 2,653,883 | 8.1M $ | 0.11 % |
| 145 | Invivyd Inc | 5,654,625 | 7.4M $ | 0.10 % |
| 146 | Perspective Therapeutics Inc | 1,713,495 | 7.1M $ | 0.10 % |
| 147 | DAMORA THERAPEUTICS INC | 93,797 | 2.4M $ | 0.03 % |
Sector breakdown
- Health care 14.8 %
- Unattributed 85.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 95.4 %
- Ireland 1.6 %
- Switzerland 1.1 %
- Bermuda 1.1 %
- British Virgin Islands 0.4 %
- Netherlands 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 141 | 7.1B $ | 95.45 % |
| 2 | Ireland | 2 | 117.4M $ | 1.58 % |
| 3 | Switzerland | 1 | 80.7M $ | 1.09 % |
| 4 | Bermuda | 1 | 79.3M $ | 1.07 % |
| 5 | British Virgin Islands | 1 | 32.5M $ | 0.44 % |
| 6 | Netherlands | 1 | 27.8M $ | 0.37 % |
Cite this page
Titelia. "Holdings of State Street(R) SPDR(R) S&P(R) Biotech ETF". https://titelia.com/en/funds/S000010018